KEGG   Gorilla gorilla gorilla (western lowland gorilla): 101142032
Entry
101142032         CDS       T02442                                 
Symbol
BID
Name
(RefSeq) BH3-interacting domain death agonist
  KO
K04726  BH3 interacting domain death agonist
Organism
ggo  Gorilla gorilla gorilla (western lowland gorilla)
Pathway
ggo01524  Platinum drug resistance
ggo04071  Sphingolipid signaling pathway
ggo04115  p53 signaling pathway
ggo04210  Apoptosis
ggo04215  Apoptosis - multiple species
ggo04217  Necroptosis
ggo04650  Natural killer cell mediated cytotoxicity
ggo04932  Non-alcoholic fatty liver disease
ggo05010  Alzheimer disease
ggo05014  Amyotrophic lateral sclerosis
ggo05022  Pathways of neurodegeneration - multiple diseases
ggo05152  Tuberculosis
ggo05160  Hepatitis C
ggo05161  Hepatitis B
ggo05162  Measles
ggo05163  Human cytomegalovirus infection
ggo05164  Influenza A
ggo05167  Kaposi sarcoma-associated herpesvirus infection
ggo05168  Herpes simplex virus 1 infection
ggo05169  Epstein-Barr virus infection
ggo05170  Human immunodeficiency virus 1 infection
ggo05200  Pathways in cancer
ggo05416  Viral myocarditis
ggo05417  Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:ggo00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04071 Sphingolipid signaling pathway
    101142032 (BID)
 09140 Cellular Processes
  09143 Cell growth and death
   04210 Apoptosis
    101142032 (BID)
   04215 Apoptosis - multiple species
    101142032 (BID)
   04217 Necroptosis
    101142032 (BID)
   04115 p53 signaling pathway
    101142032 (BID)
 09150 Organismal Systems
  09151 Immune system
   04650 Natural killer cell mediated cytotoxicity
    101142032 (BID)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    101142032 (BID)
  09172 Infectious disease: viral
   05170 Human immunodeficiency virus 1 infection
    101142032 (BID)
   05161 Hepatitis B
    101142032 (BID)
   05160 Hepatitis C
    101142032 (BID)
   05164 Influenza A
    101142032 (BID)
   05162 Measles
    101142032 (BID)
   05168 Herpes simplex virus 1 infection
    101142032 (BID)
   05163 Human cytomegalovirus infection
    101142032 (BID)
   05167 Kaposi sarcoma-associated herpesvirus infection
    101142032 (BID)
   05169 Epstein-Barr virus infection
    101142032 (BID)
  09171 Infectious disease: bacterial
   05152 Tuberculosis
    101142032 (BID)
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    101142032 (BID)
   05014 Amyotrophic lateral sclerosis
    101142032 (BID)
   05022 Pathways of neurodegeneration - multiple diseases
    101142032 (BID)
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    101142032 (BID)
   05416 Viral myocarditis
    101142032 (BID)
  09167 Endocrine and metabolic disease
   04932 Non-alcoholic fatty liver disease
    101142032 (BID)
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    101142032 (BID)
SSDB
Motif
Pfam: BID Bcl-2 DUF4618 CRM1_C
Other DBs
NCBI-GeneID: 101142032
NCBI-ProteinID: XP_004063032
Ensembl: ENSGGOG00000010562
UniProt: G3R4T6
Position
22:complement(1254149..1294723)
AA seq 195 aa
MDCEVNNGSGLRDECITNLLVFGFLQSCSDNSFRRELDALGHELPVLAPQWEGYDELQTD
GNRSSHSRLGRIEADSESQEDIIRNIARHLAQVGDSMDRSIPPGLVNGLALQLRNTSRSE
EDRNRDLATALEQLLQAYPRDMEKEKTMLVLALLLAKKVASHTPSLLRDVFHTTVNFINQ
NLRTYVRSLARNGMD
NT seq 588 nt   +upstreamnt  +downstreamnt
atggactgtgaggtcaacaacggttccggcctcagggatgagtgcatcacaaacctactg
gtgtttggcttcctccaaagctgctctgacaacagcttccgcagagagctggacgcactg
ggccacgagctgccagtgctggctccccagtgggagggctacgatgagctgcagactgac
ggcaaccgcagcagccactcccgcttgggaagaatagaggcagattctgaaagtcaagaa
gacatcatcaggaatattgccaggcacctcgcccaggtcggggacagcatggaccgtagc
atccctccgggcctggtgaacggcctggccctgcagctcaggaacaccagccggtcggag
gaggaccggaacagggacctggccactgccctggagcagctgctgcaggcctaccctaga
gacatggagaaggagaagaccatgctggtgctggccctgctgctggccaagaaggtggcc
agtcacacgccgtccttgctccgtgatgtctttcacacaacagtgaattttattaaccag
aacctacgcacctacgtgaggagcttagccagaaatgggatggactga

DBGET integrated database retrieval system